Market Research Logo

POCT Market in Europe 2015-2019

About POCT Market in Europe

POCT is the fastest growing segment of laboratory diagnostics in Europe. It is performed using electronic and non-electronic devices that range from reaction strips to bulky devices. These devices replace a series of laboratory experiments and reduce the turnaround time. POCT diagnostic devices can be categorized into hand-held and near-bedside monitoring devices. The hand-held POCT devices are small, offering mobility while the near-bedside POCT devices are larger and complex. For both the devices, quality control and calibration functionality are checked before performing the tests.

Technavio’s analysts forecast the POCT market in Europe to grow at a CAGR of 4.07% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the point-of-care testing (POCT) market in Europe for the period 2015-2019. To calculate the market size, the report considers the revenue generated from sales of POCT diagnostic devices, including instruments and consumables

The market is divided into the following segments based on application:

  • Blood glucose testing
  • Infectious diseases testing
  • Cardiac markers testing
  • Coagulation testing
  • Pregnancy and fertility testing
  • Electrolyte testing
  • Tumor markers testing
  • Urinalysis
  • Cholesterol testing
Technavio's report, POCT Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott Laboratories
  • Alere
  • Bayer Healthcare
  • LifeScan
  • Roche Diagnostics
  • Siemens
Other
    prominent vendors
  • Abaxis
  • A. Menarini Diagnostics
  • Acon Laboratories
  • BD
  • Beckman Coulter
  • Bio-Rad Laboratories
  • Cepheid
  • Chembio Diagnostic Systems
  • Clarity Diagnostics
  • DiagCor
  • Helena Laboratories
  • Hologic
  • Life Technologies
  • Landwind Medical
  • Mindray
  • i-Sens
  • Nipro Diagnostics
  • Randox Laboratories
  • Span Diagnostics
  • Snibe Diagnostics
  • Sysmex
  • Trivitron Healthcare
  • URIT
Market
    driver
  • Patient-driven demand
  • For a full, detailed list, view our report
Market
    challenge
  • Direct-to-consumer genetic testing
  • For a full, detailed list, view our report
Market
    trend
  • Government initiatives for quality improvement
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – POCT Market in Europe 2015-2019

Technavio recognizes the following companies as the key players in the POCT Market in Europe: Abbott Laboratories, Alere, Bayer Healthcare, LifeScan, Roche Diagnostics and Siemens.

Other Prominent Vendors in the market are: Abaxis, A. Menarini Diagnostics, Acon Laboratories, BD, Beckman Coulter, Bio-Rad Laboratories, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, DiagCor, Helena Laboratories, Hologic, Life Technologies, Landwind Medical, Mindray, i-Sens, Nipro Diagnostics, Randox Laboratories, Span Diagnostics, Snibe Diagnostics, Sysmex, Trivitron Healthcare, and URIT.

Commenting on the report, an analyst from Technavio’s team said: “The increasing use of POCT devices is forcing governments to monitor the quality of these devices to ensure patient safety. Norway leads in POCT quality control. The Norwegian Center for External Quality Assurance in Primary Health Care (NOKULAS) aims to produce information concerning the quality of laboratory equipment.”

According to the report, high prevalence of diseases and increased awareness about diseases and the advances in medicine are driving individuals to opt for preventative and control measures.

Further, the report states that the reimbursement structure is not uniform in the EU as each member state has its own policies for reimbursement approval by public or private insurance companies or both.

Companies Mentioned

Abbott Laboratories, Alere, Bayer Healthcare, LifeScan, Roche Diagnostics, Siemens, Abaxis, A. Menarini Diagnostics, Acon Laboratories, BD, Beckman Coulter, Bio-Rad Laboratories, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, DiagCor, Helena Laboratories, Hologic, Life Technologies, Landwind Medical, Mindray, i-Sens, Nipro Diagnostics, Randox Laboratories, Span Diagnostics, Snibe Diagnostics, Sysmex, Trivitron Healthcare, URIT.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table POCT market in Europe 2015-2019 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • POCT testing: Overview
    • Table Difference between diagnostic test and laboratory testing process
    • Conformité Européene (CE) approval in Europe
      • Table Approval of self-testing IVD
    • POCT market scenario in Europe
      • Table Market share of POCT market in Europe by country
  • Market segmentation by application
    • Table Segmentation of POCT market by application
    • Blood glucose testing market in Europe
      • Table Blood glucose testing market in Europe 2014-2019 ($ millions)
    • Infectious diseases testing market in Europe
      • Table Infectious disease testing market in Europe 2014-2019 ($ millions)
    • Cardiac markers testing market in Europe
      • Table Cardiac markers testing market in Europe 2014-2019 ($ millions)
    • Coagulation testing market in Europe
      • Table Coagulation testing market in Europe 2014-2019 ($ millions)
    • Blood gas and electrolytes testing market in Europe
      • Table Blood gas and electrolytes testing market in Europe 2014-2019 ($ millions)
    • Pregnancy and fertility testing market in Europe
      • Table Pregnancy and fertility testing market in Europe 2014-2019 ($ millions)
    • Tumor markers testing market in Europe
      • Table Tumor marker testing market in Europe 2014-2019 ($ millions)
    • Cholesterol testing market in Europe
      • Table Cholesterol testing market in Europe 2014-2019 ($ millions)
    • Urinalysis market in Europe
      • Table Urinalysis market in Europe 2014-2019 ($ millions)
      • Table POCT market share by products
  • Market drivers
    • Patient-driven demand
    • Coverage of POCT devices in developed countries
    • Technological innovations
    • Increased healthcare spending
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Direct-to-consumer (DTC) genetic testing
    • Pricing structure of European healthcare
    • Threat from low-cost products
    • Technology limitations
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Government initiatives for quality improvement
    • Patient-centered healthcare by digital technology
    • Growing popularity of portable POCT products
    • Next-generation sequencing and DNA microarrays
  • Vendor landscape
    • Competitive scenario
    • Abbott Diagnostics
      • Table Abbott Diagnostics: Key takeaways
    • Alere
      • Table Alere: Key takeaways
    • LifeScan
      • Table LifeScan: Key takeaways
    • Roche Diagnostics
      • Table Roche Diagnostics: Key takeaways
    • Siemens Diagnostics
      • Table Siemens Diagnostics: Key takeaways
    • Other prominent vendors
  • Key vendor analysis
    • Abbott Diagnostics
      • Table Abbott Diagnostics: key business offerings
    • Alere
      • Table Alere: Business Segmentation by revenue 2014
      • Table Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
      • Table Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
    • LifeScan
    • Roche Diagnostics
      • Table Roche Diagnostics: Business segmentation by revenue 2014
      • Table Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
      • Table Roche Diagnostics: Geographical segmentation by revenue 2014
    • Siemens Healthcare
      • Table Siemens Healthcare: Business segmentation
      • Table Siemens Healthcare: Geographical segmentation by revenue 2014
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report